课题基金 / 基金详情

Project MISSION: Developing a multicomponent, Multilevel Implementation Strategy for Syncope OptImalCare thrOugh eNgagement

Project MISSION: Developing a multicomponent, Multilevel Implementation Strategy for Syncope OptImalCare thrOugh eNgagement
项目使命:通过参与制定晕厥优化护理的多组成部分、多层次实施策略
批准号:
9755244
负责人:
Jing Li
金额:
$50.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-15 至 2021-07-31

项目摘要

项目成果

Jing Li的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Abstract Syncope is a complex presenting symptom that requires thoughtful and efficient evaluation to determine the etiology of a patient's loss of consciousness. Prevalence rates of syncope have been reported as high as 41%, with recurrent syncope occurring in 13.5%. A common symptom, approximately 1% to 3% of all emergency department (ED) visits (as many ED visits as atrial fibrillation) and up to 6% of all hospital admissions are due to syncope. The prognosis among patients with syncope depends on the etiology and underlying cardiovascular condition. A cardiac etiology of syncope is associated with significantly higher rates of morbidity and mortality than other causes such as vasovagal reflex mediated or orthostatic hypotension. The Framingham study documented a doubling of the risk of death among participants with cardiac syncope compared with those with non-cardiac syncope. Notably, experiencing syncope affects patients' quality of life (QoL), and those with more frequent syncope report poorer QoL with perceptions of low overall physical and mental health and impairment in activities of daily living. The QoL among patients with recurrent syncope appears equivalent to severe rheumatoid arthritis and chronic low-back pain in an adult population. Though research in the past 25 years provides substantial understanding of the pathophysiology of particular etiologies of syncope, the diagnostic approach to such a perplexing symptom remains difficult and efficient diagnosis remains elusive. The major challenge in the evaluation of patients with syncope is that most patients are asymptomatic at the time of their presentation. Because of concerns that patients presenting with syncope are at risk for an impending catastrophic event, overuse and inappropriate use of testing and hospital admission are common. Aiming to provide guidance on optimizing the evaluation and management of syncope, a collaboration of the American College of Emergency Physicians, Society for Academic Emergency Medicine, American College of Cardiology (ACC), American Heart Association (AHA) and Heart Rhythm Society (HRS) issued a Guideline for the Evaluation and Management of Patients with Syncope in 2017. Adopting a standardized approach to syncope based on this guideline offers an effective opportunity for delivering high value care to patients suffering this distressing and potentially dangerous event. Aiming for more rapid translation from guideline to clinical practice and improved health, the proposed study will identify barriers and facilitators for implementation of an evidence-based, high value approach to diagnosis and management of patients presenting with syncope. The research team will develop a multi-level, multi-component implementation strategy for evidence-based syncope evaluation and management and plan for a subsequent hybrid effectiveness-implementation trial, guided by the Consolidated Framework for Implementation Research (CFIR).
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ajem.2020.05.029
发表时间: 2020-09
期刊: The American journal of emergency medicine
影响因子: --
作者: [Li J, Gupta V, Smyth SS, Cowley A, Du G, Sirrine M, Stearley S, Chadha R, Bhalla V, Williams MV]
通讯作者: Williams MV
DOI: 10.2196/25192
发表时间: 2021-11-16
期刊: Journal of medical Internet research
影响因子: 7.4
作者: [Amin S, Gupta V, Du G, McMullen C, Sirrine M, Williams MV, Smyth SS, Chadha R, Stearley S, Li J]
通讯作者: Li J
DOI: 10.2147/ppa.s307186
发表时间: 2021
期刊: Patient preference and adherence
影响因子: 2.2
作者: [Clouser JM, Sirrine M, McMullen CA, Cowley AM, Smyth SS, Gupta V, Williams MV, Li J]
通讯作者: Li J
DOI: 10.3390/medicina57060570
发表时间: 2021-06-03
期刊: Medicina (Kaunas, Lithuania)
影响因子: --
作者: [Li J, Smyth SS, Clouser JM, McMullen CA, Gupta V, Williams MV]
通讯作者: Williams MV
AIDen: An AI-empowered detection and diagnosis system for jaw lesions using CBCT
  • 批准号:
    10383494
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2022
  • 负责人:
    Jing Li
  • 依托单位:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
  • 批准号:
    10674753
  • 项目类别:
  • 资助金额:
    $36.94万
  • 财政年份:
    2021
  • 负责人:
    Jing Li
  • 依托单位:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
  • 批准号:
    10459595
  • 项目类别:
  • 资助金额:
    $37.32万
  • 财政年份:
    2021
  • 负责人:
    Jing Li
  • 依托单位:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
  • 批准号:
    10298016
  • 项目类别:
  • 资助金额:
    $39.43万
  • 财政年份:
    2021
  • 负责人:
    Jing Li
  • 依托单位: